Leerink Partners Sticks to Their Hold Rating for Phathom Pharmaceuticals (PHAT)
at www.tipranks.com (Mon, 2-Nov 11:42 AM)
Phathom’s VOQUEZNA hits 2 million prescriptions as Q3 revenue reaches $84.7 million
Market Chameleon (Thu, 29-Oct 8:34 AM)
PHAT Rises as Litigation Targets FDA’s VOQUEZNA Exclusivity Through 2032
Market Chameleon (Mon, 26-Oct 11:54 AM)
